Goldman Sachs Group Inc Apyx Medical Corp Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	SELL	$2.45 - $3.59 $10,079 - $14,769	-4,114 Reduced 18.5%	18,127 $52,000
Q1 2023 May 11, 2023	BUY	$2.45 - $3.59 $44,411 - $65,075	18,127 New	18,127 $52,000
Q2 2022 May 14, 2024	BUY	$3.11 - $7.5 $69,169 - $166,807	22,241 New	22,241 $130,000
Q2 2022 Aug 15, 2022	BUY	$3.11 - $7.5 $17,353 - $41,850	5,580 Added 33.49%	22,241 $130,000
Q1 2022 May 16, 2022	SELL	$5.87 - $13.13 $552,120 - $1.23 Million	-94,058 Reduced 84.95%	16,661 $109,000
Q4 2021 Feb 14, 2022	SELL	$12.15 - $17.4 $637,741 - $913,308	-52,489 Reduced 32.16%	110,719 $1.42 Million
Q3 2021 Nov 10, 2021	BUY	$8.79 - $13.96 $1.43 Million - $2.28 Million	163,208 New	163,208 $2.26 Million

14.3M

360K

Ticker APYX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,573,000
Market Cap $42.5M
Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.